Organigram Global Inc (OGI) FinancialsOGIOrganigram Global Inc

Evaluating the bottom line, Organigram Global Inc maintains a gross margin of 23.06%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -11.06%, while the net margin is 99.77%. These profitability ratios, combined with a Return on Equity (ROE) of 19.89%, provide a clear picture of how effectively OGI converts its operational activities into shareholder value.

In the context of the broader market, OGI competes directly with industry leaders such as LMNR and AFRI. With a market capitalization of $173.44M, it holds a significant position in the sector. When comparing efficiency, OGI's gross margin of 23.06% stands against LMNR's -1.02% and AFRI's 10.42%. Such benchmarking helps identify whether Organigram Global Inc is trading at a premium or discount relative to its financial performance.

The company has demonstrated significant revenue growth, with Q3 2026 net revenue reaching 105.8 million CAD, a 49% increase year-over-year. This is supported by a strong adjusted EBITDA of 13.4 million CAD, indicating improved profitability.